The Role of Biosimilars in Patient Access to Therapeutic Antibodies for Immune Mediated Inflammatory Diseases.
Sign Up to like & getrecommendations! Published in 2017 at "Current pharmaceutical design"
DOI: 10.2174/1381612824666171129192607
Abstract: BACKGROUND Biosimilars have the potential to create competition, lower costs, and increase patient access to biological medications. However, biological medications are sensitive to their manufacturing processes and difficult to precisely characterize, leading to questions about… read more here.
Keywords: therapeutic antibodies; biosimilars patient; patient access; access therapeutic ... See more keywords
A Review of Synthetic Access to Therapeutic Compounds Extracted from Psilocybe
Sign Up to like & getrecommendations! Published in 2022 at "Pharmaceuticals"
DOI: 10.3390/ph16010040
Abstract: Psychedelics are used for various pathologies of the central nervous system and are currently the subject of much research, some of which relates to the compounds contained in various Psilocybe-type hallucinogenic mushrooms. It is difficult,… read more here.
Keywords: access therapeutic; synthetic access; review synthetic; therapeutic compounds ... See more keywords